Children and adolescents with Cushing’s disease who have subclinical bleeding near their disease-driving tumors may respond differently to tests…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
For people with Cushing’s disease who have pituitary tumors that are not visible by MRI, careful exploratory surgery coupled…
Mutations in the GPR101 and USP8 genes might have contributed to the growth of a particularly large and aggressive pituitary tumor that…
Treatment with Isturisa (osilodrostat) normalized urine cortisol levels up to nearly 1.5 years in people with Cushing’s disease,…
The case of a woman with a rare form of Cushing’s syndrome whose main symptom was blurry vision was described…
Continuous treatment with Recorlev (levoketoconazole) helped to lower blood cholesterol levels in adults with endogenous Cushing’s syndrome, according to…
High levels of the hormone precursor copeptin following surgery might be associated with remission in people with Cushing’s disease…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
A new surgical technique pioneered at the Carling Adrenal Center in Florida allows for faster recovery of adrenal gland function…
Treatment with Isturisa (osilodrostat) rapidly normalized cortisol levels, eased symptoms, and improved the quality of life for people with…